期刊文献+

类风湿关节炎发生发展中TNF-α信号通路与CD4^+T细胞的关系 被引量:42

Relationship between TNF-α signaling pathway and the function of CD4+T cell subsets in rheumatoid arthritis
下载PDF
导出
摘要 CD4+T细胞各亚群在类风湿关节炎(RA)的发生发展过程中发挥不同的作用。其中,辅助性T细胞1(Th1)/Th2细胞、Th17/调节性T细胞(Treg)细胞比例的失衡及细胞因子白细胞介素-1(IL-1)、IL-2、干扰素-γ(IFN-γ)、肿瘤坏死因子-α(TNF-α)等产生的免疫损害,是导致RA慢性炎症的关键因素。TNF-α作为一种重要的促炎细胞因子在RA致病过程中起到了重要作用。TNF-α有两个受体,TNF受体1(TNF receptor 1,TNFR1)在大多数细胞上表达,而TNFR2仅在T细胞等免疫细胞上表达,调节T细胞的存活、活化和增殖。反之,T细胞对TNF-α信号通路也有影响。该文就RA的发病机制中TNF-α及其信号通路和CD4+T细胞各亚群功能的关系加以综述,为RA的防治提供新的思路。 CD4+ T cell subsets play different roles in the patho- genesis of rheumatoid arthritis (RA). The helper T (Thl)/Th2 and Thl7/regulatory T cells (Treg) imbalance and pro-inflamma- tory cytokines, such as interleukin-1 ( IL-1 ), IL-2, interferon-γ (IFN-γ) and tumor necrosis factor-α(TNF-α), are the key fac- tors in the chronic inflammation of RA. TNF-α interacts with two different receptors, designated TNF receptor 1 (TNFR1) and TNFR2, which are expressed in different cells and tissues. TN-FR1 is expressed in most cells. However, TNFR2 is only ex- pressed in T cells and other immune cells which regulate the sur- vival, activation and proliferation of T-lymphocytes. This review summarizes the relationship between TNF-α signaling pathway and the function of CD4+ T cell subsets in the pathogenesis of RA in an attempt to provide new ideas for the treatment of RA.
出处 《中国药理学通报》 CAS CSCD 北大核心 2013年第7期900-903,共4页 Chinese Pharmacological Bulletin
基金 国家自然科学基金资助项目(No 81173075 81202541) 安徽省自然科学基金资助项目(No 1208085QH146) 安徽省高等学校省级优秀青年人才基金项目(No2010SQRL079) 杨森科学研究委员会中国分会研究基金项目(2011) 安徽医科大学博士学术科研活动资助项目(No XJ201213)
关键词 类风湿关节炎 CD4+T细胞亚群 TNF-Α 信号转导通路 细胞因子 相互作用 rheumatoid arthritis CD4+ T lymphocytes TNF-α signaling pathway cytokines interaction
  • 相关文献

参考文献29

  • 1Panayi G S, Corrigall V M, Pitzalis C. Pathogenesis of rheumatoid arthritis: the role of T cells and other beasts [ J ]. Rheum Dis Clin North Am, 2001,27(2) :317 -34.
  • 2Boissier M C. Cell and cytokine imbalances in rheumatoid synovi- tis[J]. Joint Bone Spine, 2011,78(3) :230 -4.
  • 3张玲玲,魏伟.针对类风湿关节炎分子靶点的治疗药物研究进展[J].中国药理学通报,2006,22(11):1291-1296. 被引量:17
  • 4Wei X W, Gong J F, Zhu J. The suppressive effect of triptolide on chronic colitis and TNF-a/TNFR2 signal pathway in interleukin- 10 deficient mice[J]. Clin Immunol, 2008,129:211 -8.
  • 5Notley C A, Inglis J J, Alzabin S, et al. Blockade of tumor necro- sis factor in collagen-induced arthritis reveals a novel immunoregu- latory pathway for Thl and Thl7 cells[J]. J Exp Med, 2008,205 (11) :2491 -7.
  • 6Yoo H J, Byun H J, Kiln B R, et al. DAPkl inhibits NF-κB acti- vation through TNF-α and INF-γ-induced apoptosis [ J ]. Cell Sig- nal, 2012,24(7) :1471 -7.
  • 7Wesemann D R, Benveniste E N. STAT-1α and IFN-γ as modula- tors of TNF-α signaling in nmcrophages : regulation and functional implications of the TNF receptor 1: STAT-1α complex[J]. J lm- munol, 2003,171(10) :5313 -9.
  • 8Mclnnes I B,Leung B P,Sturrock R D,et al. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-alpha production in rheumatoid arthritis[J]. Nat Meal,1997,3(2) :189 -95.
  • 9Bryce P J, Oyoshi M K, Kawamoto S, et al. TRAF1 regulates Th2 differentiation, allergic inflammation and nuclear localization of the Th2 transcription factor, NIP45 [J]. Int lmmunol, 2006,18( 1 ) : 101 -11.
  • 10So T, Salek-Ardakani S, Nakano H, et al. TNF receptor-associat- ed factor 5 limits the induction of Th2 immune responses [ J ]. J lmmunol, 2004,172(7) :4292 -7.

二级参考文献26

  • 1吴丽,魏伟.类风湿关节炎中血管生成的分子机制[J].中国药理学通报,2004,20(10):1098-1101. 被引量:15
  • 2Lee S J,Kavanaugh A.Pharmacological treatment of established rheumatoid arthritis[J].Best Pract Res Clin Rheumatol,2003,17(5):811 -29.
  • 3Atzeni F,Turiel M,Capsoni F,et al.Autoimmunity and AntiTNF-{ alpha } Agents[J].Ann N Y Acad Sci,2005,1051:559 -69.
  • 4Garfield B E,Krahl T,Appel S,et al.Regulation of p38 MAP kinase in CD4 (+) lymphocytes by infliximab therapy in patients with rheumatoid arthritis[J].Clin Immunol,2005,116 (2):101 -7.
  • 5Vigna P M,Abud M C,Portillo S H,et al.Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis[J].Clin Exp Immunol,2005,141 (2):372 -80.
  • 6Ranganathan P.Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis[J].Pharmacogenomics,2005,6(5):481 -90.
  • 7Horai R,Nakajima A,Habiro K,et al.TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice[J].J Clin Invest,2004,114(11):1603 -11.
  • 8Fleischmann R,Stern R,Iqbal I.Anakinra:an inhibitor of IL-1 for the treatment of rheumatoid arthritis[J].Expert Opin Biol Ther,2004,4(8):1333 -44.
  • 9Vila A T,Puig L,Laiz A M,et al.Adverse cutaneous reactions to anakinra in patients with rheumatoid arthritis:clinicopathological study of five patients[J].Br J Dermatol,2005,153(2):417 -23.
  • 10Smeets R L,Joosten L A,Arntz O J,et al.Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist[J].Arthritis Rheum,2005,52(7):2202-11.

共引文献16

同被引文献510

引证文献42

二级引证文献310

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部